SCHEMBL4833991

SCHEMBL4833991

COc1cccc(S(=O)(=O)Nc2ccc(N3CN=c4occc4=C3N)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.49
▸ PKM P14618 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ GAA P10253 2/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ PGR P06401 4/20 0.48
▸ CYP11B1 P15538 1/20 0.46
▸ CYP11B2 P19099 1/20 0.46
▸ HPGD P15428 1/20 0.44
▸ PTPN2 P17706 2/20 0.44
▸ PTPN1 P18031 2/20 0.44
▸ PTPN5 P54829 2/20 0.44
▸ HSPD1 P10809 1/20 0.44
▸ HSPE1 P61604 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ RORA P35398 1/20 0.44
▸ RORC P51449 1/20 0.44
▸ NR1H2 P55055 1/20 0.44
▸ BRD4 O60885 1/20 0.42
▸ HTR6 P50406 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829045 0.92 KMT2A (0.41) ALDH1A1PKMLMNAGAASMN1; SMN2
SCHEMBL4831475 0.89 KMT2A (0.52) ALDH1A1PKMLMNAGAASMN1; SMN2
SCHEMBL4829088 0.87 PGR (0.47) ALDH1A1PKMLMNAGAASMN1; SMN2
SCHEMBL4829091 0.86 KMT2A (0.44) ALDH1A1PKMLMNASMN1; SMN2PGR
SCHEMBL4834398 0.86 MAPT (0.47) ALDH1A1PKMLMNAPGRPTPN2
SCHEMBL4833946 0.85 KEAP1 (0.46) ALDH1A1PKMLMNAPGRHPGD
SCHEMBL4836848 0.84 ALPL (0.51) ALDH1A1LMNASMN1; SMN2BRD4
SCHEMBL4830862 0.82 PGR (0.44) LMNAGAAPGRPTPN2PTPN1
SCHEMBL4829022 0.81 MAPT (0.49) ALDH1A1LMNAPGRPTPN2PTPN1
SCHEMBL4834472 0.81 CYP3A4 (0.47) PGRHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US claimed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US claimed
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US disclosed
US-7427623-B2 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof SMITHKLINE BEECHAM CORPORATION (US) 2008-09-23 — — US disclosed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US disclosed
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004142-A1 Chemical compounds TIE1, KDR, TEK ALDH1A1 906/4885PKM 1959/4885LMNA 4230/4885
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF TIE1, TEK, KDR ALDH1A1 1144/4885PKM 1886/4885LMNA 4131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback